Stabilization of Brain Mast Cells Alleviates LPS-Induced Neuroinflammation by Inhibiting Microglia Activation.

LPS mast cells microglia activation migtation neuroinflammation

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2019
Historique:
received: 11 02 2019
accepted: 16 04 2019
entrez: 28 5 2019
pubmed: 28 5 2019
medline: 28 5 2019
Statut: epublish

Résumé

The functional aspects of mast cell-microglia interactions are important in neuroinflammation. Our previous studies have demonstrated that mast cell degranulation can directly induce microglia activation. However, the role of mast cells in Lipopolysaccharide (LPS)-induced microglia activation, neuroinflammation and cognitive impairment has not been clarified. This study investigated the interaction between brain microglia and mast cells In this study, intraperitoneal injection of 1 mg/kg LPS induced mast cell activation in hypothalamus and cognitive dysfunction in rats, and that this process can be repressed by the mast cell stabilizer cromolyn (200 μg). Meanwhile, in mice, LPS IP injection induced significant microglia activation 24 h later in the hypothalamus of wild-type (WT) mice, but had little effect in Kit Taken together, our results demonstrate that stabilization of mast cells can inhibit LPS-induced neuroinflammation and memory impairment, suggesting a novel treatment strategy for neuroinflammation-related diseases.

Sections du résumé

BACKGROUND BACKGROUND
The functional aspects of mast cell-microglia interactions are important in neuroinflammation. Our previous studies have demonstrated that mast cell degranulation can directly induce microglia activation. However, the role of mast cells in Lipopolysaccharide (LPS)-induced microglia activation, neuroinflammation and cognitive impairment has not been clarified.
METHODS METHODS
This study investigated the interaction between brain microglia and mast cells
RESULTS RESULTS
In this study, intraperitoneal injection of 1 mg/kg LPS induced mast cell activation in hypothalamus and cognitive dysfunction in rats, and that this process can be repressed by the mast cell stabilizer cromolyn (200 μg). Meanwhile, in mice, LPS IP injection induced significant microglia activation 24 h later in the hypothalamus of wild-type (WT) mice, but had little effect in Kit
CONCLUSION CONCLUSIONS
Taken together, our results demonstrate that stabilization of mast cells can inhibit LPS-induced neuroinflammation and memory impairment, suggesting a novel treatment strategy for neuroinflammation-related diseases.

Identifiants

pubmed: 31130850
doi: 10.3389/fncel.2019.00191
pmc: PMC6509474
doi:

Types de publication

Journal Article

Langues

eng

Pagination

191

Références

J Comp Neurol. 2000 Sep 4;424(4):651-69
pubmed: 10931487
Nature. 2001 Sep 27;413(6854):420-5
pubmed: 11574888
Glia. 2002 Nov;40(2):133-9
pubmed: 12379901
J Pharmacol Exp Ther. 2002 Dec;303(3):1061-6
pubmed: 12438528
Neuron. 2003 Sep 11;39(6):889-909
pubmed: 12971891
Annu Rev Immunol. 2005;23:749-86
pubmed: 15771585
Glia. 2005 Aug 15;51(3):199-208
pubmed: 15800925
Eur J Pharmacol. 2005 May 16;515(1-3):179-87
pubmed: 15904918
Prog Neurobiol. 2005 Jun;76(2):77-98
pubmed: 16081203
J Biochem Biophys Methods. 2006 Nov 30;69(1-2):227-31
pubmed: 16707161
Brain Res. 2007 Sep 26;1171:18-29
pubmed: 17764664
Nat Neurosci. 2007 Dec;10(12):1507-9
pubmed: 18043584
J Cereb Blood Flow Metab. 2010 Apr;30(4):689-702
pubmed: 20087366
J Neurosci Res. 2010 Jun;88(8):1615-31
pubmed: 20127816
J Immunol. 2010 Jun 15;184(12):6891-900
pubmed: 20488789
Eur J Immunol. 2011 Jun;41(6):1764-73
pubmed: 21469095
Cell Immunol. 2011;270(2):164-71
pubmed: 21620385
Cytokine. 2012 May;58(2):178-85
pubmed: 22305008
Int Arch Allergy Immunol. 2012;159(1):23-32
pubmed: 22555146
Cell Physiol Biochem. 2012;29(5-6):931-40
pubmed: 22613992
Anesthesiology. 2013 May;118(5):1098-105
pubmed: 23353794
Trends Neurosci. 2013 Sep;36(9):513-21
pubmed: 23845731
Immunology. 2014 Mar;141(3):314-27
pubmed: 24032675
N Engl J Med. 1987 Jul 2;317(1):30-4
pubmed: 2438554
Mol Neurobiol. 2014 Jun;49(3):1487-500
pubmed: 24752587
Brain Behav Immun. 2015 Feb;44:221-34
pubmed: 25449673
J Neuroinflammation. 2015 Sep 15;12:165
pubmed: 26373740
Behav Brain Res. 2016 Feb 1;298(Pt B):158-66
pubmed: 26554724
Mol Neurobiol. 2017 Mar;54(2):997-1007
pubmed: 26797518
J Neuroinflammation. 2016 May 31;13(1):127
pubmed: 27245661
Neuroscientist. 2017 Oct;23(5):478-498
pubmed: 29283023
Ann Allergy. 1987 Apr;58(4):226-35
pubmed: 3105366
N Engl J Med. 1993 Jan 28;328(4):257-65
pubmed: 8418407
Int Arch Allergy Immunol. 1997 Sep;114(1):1-9
pubmed: 9303324

Auteurs

Hongquan Dong (H)

Clinical Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Yiming Wang (Y)

Infection and Immunity Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
School of Medicine, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.

Xiaojun Zhang (X)

Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Xiang Zhang (X)

Department of Anesthesiology, Shanghai First People's Hospital, Shanghai, China.

Yanning Qian (Y)

Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Haixia Ding (H)

Department of Geriatric, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Shu Zhang (S)

Clinical Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Classifications MeSH